Fisher v Natal Rubber Compounders (Pty) Ltd

On 10 November 2010, George Beaton trading as Meranti issued a summons against Fisher claiming payment of R1,077,377 for goods sold and delivered to Strongwood Manufacturing (Pty) Ltd (in liquidation), for which Fisher had stood surety. Summons was served on 18 November 2010. Fisher filed his plea on the merits on 7 January 2011. On 22 October 2013, Meranti ceded all its rights, title and interest in the claim to NRC. On 9 December 2013 Meranti served notice in terms of Uniform Rule 28(1) to amend the summons by substituting NRC as plaintiff. Fisher did not oppose the amendment. On 22 January 2014, Fisher amended his plea to raise a special plea, contending that upon cession and substitution of NRC, Meranti's interruption of prescription had lapsed and the claim had prescribed in terms of sections 15(2) and (6) of the Prescription Act 68 of 1969. The matter proceeded on a stated case and separation of issues.

• Whether the substitution of a cessionary for a cedent after litis contestatio amounted to the institution of fresh proceedings
• Whether the interruption of prescription effected by the cedent's service of summons ceased to be effective upon substitution of the cessionary as plaintiff
• Whether the debt had prescribed in terms of sections 15(2) and (6) of the Prescription Act 68 of 1969
• The legal effect of cession of a claim after litis contestatio on prescription

The appeal was dismissed with costs including the costs of two counsel. The special plea of prescription failed. The judgment of the KwaZulu-Natal Local Division (Gyanda J) dismissing the special plea of prescription was upheld.

When a claim is ceded after litis contestatio and the cessionary is substituted as plaintiff without objection from the defendant, this does not constitute the commencement of fresh proceedings for purposes of prescription under sections 15(2) and (6) of the Prescription Act 68 of 1969. The interruption of prescription effected by the cedent's service of summons continues to be effective because: (i) the underlying debt remains unchanged; (ii) the process (summons) under which the debt is pursued remains the same; (iii) there is essential continuity in pursuing the claim; (iv) the cessionary steps into the shoes of the cedent and acquires a claim in respect of which prescription has already been interrupted; and (v) any judgment will be granted in terms of the original summons and particulars of claim. The substitution is merely a procedural step that does not affect the interruption of prescription. After litis contestatio, what is ceded is not the claim itself but the interest in the result of the litigation.

Mathopo JA observed that it would be absurd to hold that the effect of substitution was to create a defence of prescription where none previously existed. If Meranti had simply continued to pursue the action in its own name (either by agreement with NRC or because the court refused substitution), the point of prescription would not have arisen, yet the claim would still have been pursued for NRC's benefit. The court also noted that there are sound practical reasons for the rule that a cessionary must apply for substitution to acquire locus standi, while the cedent does not lose locus standi until such substitution occurs. The court commented that a cession may be framed to relate explicitly to the spes (expectation of benefits from successful conclusion of proceedings), and that there may be three factors involved in cession: (i) the original founding right, (ii) the right arising from litis contestatio to proceed with the action to its conclusion, and (iii) the spes in respect of the benefits flowing from successful conclusion.

This case is significant in South African law for clarifying the interaction between prescription and cession of claims after litis contestatio. It establishes important principles regarding: (1) The continuity of proceedings when a cessionary is substituted for a cedent after litis contestatio. (2) That substitution of a cessionary does not constitute fresh proceedings for purposes of prescription, provided there is continuity in pursuing the same underlying claim. (3) The distinction between ceding a claim before and after litis contestatio - after litis contestatio, what is ceded is the interest in the result of litigation, not the claim itself. (4) That the debt and process remain unchanged when a cessionary is substituted, only the identity of the creditor changes. (5) The procedural nature of substitution which does not affect the interruption of prescription by the original summons. The judgment provides important guidance for creditors seeking to cede claims and for debtors seeking to resist such claims on prescription grounds. It promotes commercial certainty by preventing technical defences of prescription arising purely from procedural substitution where there is continuity in the underlying claim.